Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Michael

Showing results (1211-1220 of 1,306) with videos related to

Pageof 131
Sort By:
Circulation. Genomic and Precision Medicine|June 19, 2019
Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic DissectionBrooke N Wolford, Whitney E Hornsby, Dongchuan Guo, et al.
JACC. Cardiovascular Interventions|May 20, 2017
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical BioprosthesesG Michael Deeb, Stanley J Chetcuti, Michael J Reardon, et al.
Circulation. Cardiovascular Interventions|October 18, 2024
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis PatientsThomas Modine, Didier Tchétché, Nicolas M Van Mieghem, et al.
Journal of the American College of Cardiology|December 28, 2010
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervalsIlan Goldenberg, Samuel Horr, Arthur J Moss, et al.
European Journal of Heart Failure|February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trialNinian N Lang, Faheem A Ahmad, John G Cleland, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
Journal of Cardiac Failure|April 28, 2023
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure SocietyHiroyuki Tsutsui, Nancy M Albert, Andrew J S Coats, et al.
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
JACC. Heart Failure|November 29, 2020
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF StudyG Michael Felker, John J V McMurray, John G Cleland, et al.
Pageof 131

Showing results (1211-1220 of 1,306) with videos related to

Sort By:
Pageof 131
Circulation. Genomic and Precision Medicine|June 19, 2019
Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic DissectionBrooke N Wolford, Whitney E Hornsby, Dongchuan Guo, et al.
JACC. Cardiovascular Interventions|May 20, 2017
1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical BioprosthesesG Michael Deeb, Stanley J Chetcuti, Michael J Reardon, et al.
Circulation. Cardiovascular Interventions|October 18, 2024
Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis PatientsThomas Modine, Didier Tchétché, Nicolas M Van Mieghem, et al.
Journal of the American College of Cardiology|December 28, 2010
Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervalsIlan Goldenberg, Samuel Horr, Arthur J Moss, et al.
European Journal of Heart Failure|February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trialNinian N Lang, Faheem A Ahmad, John G Cleland, et al.
Journal of the American College of Cardiology|January 1, 2013
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomesMarco Metra, Gad Cotter, Beth A Davison, et al.
The New England Journal of Medicine|March 4, 2011
Diuretic strategies in patients with acute decompensated heart failureG Michael Felker, Kerry L Lee, David A Bull, et al.
Journal of Cardiac Failure|April 28, 2023
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure SocietyHiroyuki Tsutsui, Nancy M Albert, Andrew J S Coats, et al.
American Heart Journal|November 27, 2019
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HFAdam D DeVore, Bradi B Granger, Gregg C Fonarow, et al.
JACC. Heart Failure|November 29, 2020
Effects of a Novel Nitroxyl Donor in Acute Heart Failure: The STAND-UP AHF StudyG Michael Felker, John J V McMurray, John G Cleland, et al.
Pageof 131